- Home
- SBH vs SVRA Comparison
SBH vs SVRA Comparison
Compare SBH & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | SVRA |
|---|---|---|
| Founded | 1964 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBH | SVRA |
|---|---|---|
| Price | $15.11 | $6.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $14.60 | $7.33 |
| AVG Volume (30 Days) | 1.6M | ★ 4.4M |
| Earning Date | 02-12-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $2.04 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $7.96 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.54 | $1.89 |
| 52 Week High | $17.40 | $7.01 |
Technical Indicators
Market Signals| Indicator | SBH | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 61.64 |
| Support Level | $14.94 | $5.86 |
| Resistance Level | $15.74 | $6.64 |
| Average True Range (ATR) | 0.48 | 0.38 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 28.68 | 47.16 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.